Sahajal Dhooria
Postgraduate Institute of Medical Education and Research, Chandigarh, India
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sahajal Dhooria as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:24 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07859839 · Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILDPost Graduate Institute of Medical Education and Research, Chandigarh · not yet recruiting · Interstitial Lung Disease · principal investigator
- Ph4NCT05626387 · An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity PneumonitisPost Graduate Institute of Medical Education and Research, Chandigarh · active not recruiting · Hypersensitivity Pneumonitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:24 UTC. The ranking covers the 200 most relevant of 35 PubMed records, and a shared surname and initials can bring in a namesake. All 35 on PubMed
- 115 citationsRCR 6.4
- A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.Eur Respir J · 2016104 citationsRCR 4.8
- A randomized trial comparing the diagnostic yield of rigid and semirigid thoracoscopy in undiagnosed pleural effusions.Respir Care · 201499 citationsRCR 5.0
- Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial.Rheumatol Int · 202097 citationsRCR 5.9
- Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India.Lancet Infect Dis · 202262 citationsRCR 6.7
- A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.Eur Respir J · 201861 citationsRCR 3.3
- A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.Eur Respir J · 202157 citationsRCR 4.6
- High-dose (40 mg) versus low-dose (20 mg) prednisolone for treating sarcoidosis: a randomised trial (SARCORT trial).Eur Respir J · 202357 citationsRCR 9.2
- 50 citationsRCR 3.5
- A pilot randomized trial of nebulized amphotericin in patients with allergic bronchopulmonary aspergillosis.J Asthma · 201648 citationsRCR 2.3